Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
EuroNanoMed aims (i) to support translational research projects that combine innovative approaches in the field of nanomedicine and (ii) to encourage and enable transnational collaboration between public and private research groups from academia, clinical/public health research or research teams from industrial enterprises (all size). The participation of Medical Doctors and SMEs will be strongly encouraged.
Característiques principals
Project proposals will address multidisciplinary and translational research. Project proposals will need to cover at least one of the following areas that are equal in relevance for this call:
  • Regenerative medicine
  • Diagnostics
  • Targeted delivery systems
    At the end, projects should fall within, but are not limited to, Technology Readiness Levels (TRL) 3-6, although for being realistic and coherent with the characteristics of the call, projects should propose advancements for a maximum of two TRL levels during their lifetime.
    • Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
    Carol Barnwell: cbarnwell@imim.es Ext.: 1670
    Marta López: mlopez4@imim.es Ext.: 1576
    Convocatòria (URL)
    https://euronanomed.net/joint-calls/12th-joint-call-2021/
    Aplicatiu web:
    https://ptoutline.eu/app/euronanomed2021
    Informació addicional
  • Submission deadline for pre-proposals: 21st January 2021
  • Submission deadline of full proposals: 10th June 2021
    • Requisits
    A consortium applying to this call will be required to include research group(s) from at least 2 of the 3 following categories, if eligible according to relevant national/regional funding organisations’ regulations for research funding:
  • Academia (research teams working in universities, other higher education institutions or research institutes);
  • Clinical/public health sector (research teams working in hospitals/public health and/or other health care settings and health organisations). Participation of Medical Doctors is encouraged;
  • Enterprise (all sizes of private companies). Participation of small and medium-size enterprises (SMEs) will be encouraged.

    Please note! Whilst applications will be submitted jointly by groups from several countries, individual groups will be funded by the individual EuroNanoMed III funding organisation respective of the country/region from which applicants have applied. The applications are therefore subjected to eligibility criteria of individual funding organisations. Applicants are strongly advised to contact their national representatives as soon as possible in order to confirm with their eligibility.

    Only transnational projects will be funded. Each consortium submitting a proposal will need to involve a minimum of 3 eligible and a maximum of 5 eligible partners from at least 3 different countries participating to the call (see list below) though no more than 2 eligible partners from the same country participating in the call will be accepted in one consortium.

    Research groups not eligible to be funded (e.g. from non-funding countries or not fundable according to national/regional regulations of the participating funding countries) may participate in transnational projects if they are able to secure their own funding. However, no more than one research group with own funding can be included in a consortium and the coordinator must be eligible to be funded by EuroNanoMed III participating countries/regions.

    The maximum number of partners will possibly be increased from 5 to 7 (including eligible for funding and non-eligible for funding research groups) if partners from these participating countries, whose scientific community has been under-represented in past EuroNanoMed calls: Bulgaria, Czech Republic, Egypt,Estonia, Latvia, Lithuania, Romania, Slovakia, Taiwan and Turkey.
    • Dotació
    For Spanish participants (ISCIII):
    Regular projects (24-36 months):
  • Up to 175.000 € per partner (overheads included)
  • Up to 250.000 € per coordinator (overheads included)
    Additional 50.000 € could be granted if there is another industrial partner funded by CDTI in the consortium.

    Short collaborative projects (12-24 months):
  • Up to 100.000 € per partner (overheads included)
  • Up to 150.000 € per coordinator (overheads included)
    Additional 50.000 € could be granted if there is another industrial partner funded by CDTI in the consortium.
    		•
    Durada
    Up to three years.
    Incompatibilitats
    Only one proposal per partner is allowed. Multiple submissions are not allowed.
    AVÍS IMPORTANT
    Spain participates in the call with 2 funding organisations: CDTI and ISCIII. Please note that IMIM is eligible through ISCIII and should follow ISCIII's eligibility and funding rules (please see pages 38-41 of the Guidelines for detailed eligibility and funding rules).

    Applicants are strongly advised to contact their relevant funding organisation contact person before submitting an application; please note that for some countries/regions it might be mandatory.

    Arxius

    Arxiu
    5_ENMIII_JTC2021_Pre-Proposal_form_VF_12112020.docx
    4_ENMIII_JTC2021-Guidelines-for-applicants_VF_12112020_corrected2.pdf
    3_ENMIII_JTC2021-Call_Text_VF_12112020.pdf